Pilot Study of the Relationship of Ambient Copeptin to the Aquaretic Effects of Tolvaptan in Patients With Heart Failure.
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
At a glance
- Drugs Tolvaptan (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 19 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 31 Jul 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 31 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.